Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $46.60 ($1.9M) on 2019-04-17, disclosed to the SEC on 2019-04-19.
Seasonal sale ($1.9M) by Chief Executive Officer — this insider has traded FGEN in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.60 | 1,318 | $61K | 3.3% |
| 2 | $46.60 | 14,836 | $691K | 37.3% |
| 3 | $47.09 | 100 | $5K | 0.3% |
| 4 | $47.17 | 3,464 | $163K | 8.8% |
| 5 | $48.75 | 100 | $5K | 0.3% |
| 6 | $45.33 | 200 |
| $9K |
| 0.5% |
| 7 | $45.69 | 3,217 | $147K | 7.9% |
| 8 | $46.82 | 8,625 | $404K | 21.8% |
| 9 | $47.13 | 1,218 | $57K | 3.1% |
| 10 | $47.34 | 6,558 | $310K | 16.7% |
| Total | $46.76 avg | 39,636 | $1.9M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |